ChromaDex gets equity funding from DSM Venturing ChromaDex Corp.

We believe the purchase demonstrates their confidence later on of ChromaDex as well as our unique business design of obtaining and commercializing novel ingredient systems. Pieter Wolters, Handling Director DSM Venturing said, We are pleased to invest in ChromaDex and thus support Frank Jaksch and the complete ChromaDex team in the growth of their business. The financial details of the investment were not disclosed.. ChromaDex gets equity funding from DSM Venturing ChromaDex Corp., CEO and co-founder of ChromaDex, commented, It is with great satisfaction and enthusiasm that people welcome DSM as a strategic investor in ChromaDex.What Is a Chiari Malformation? Chiari malformation is a condition that causes the cerebellum — the part of the brain that controls coordination and muscle movement — to push in to the space occupied by the spinal cord normally. Most kids who’ve it are born with the condition, however, many develop it because they grow. Normally, the cerebellum sits at the relative back of the skull, just above the spine. When a child has a Chiari malformation, the area for the cerebellum may also be too small or unusually shaped. This can squeeze part of the cerebellum and even part of the human brain stem down through a funnel-like hole below the skull.